BIOMARKERS
Biomarkers for Breast cancer
1. ER
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. ERBB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. ESR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. PR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. TP53
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. BRCA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. EGFR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. AKT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. BRCA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. BCL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. MYC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. MAPK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. PIK3CA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. AR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. Ki-67
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. SRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. ABCG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. JUN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. ITK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. CEACAM5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. MTOR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. PTEN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. CDKN2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. LMNA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. ROS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. MUC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. FBXW7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. FGFR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. TIMP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. CTLA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. ATM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. SERPINE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. ERBB3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. FAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. MS4A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. RB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. STAT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. uPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. HIF1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. APC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. KDR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. RHOA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. CXCR4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. KIT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. FANCA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. IL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. PSA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. TP63
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. CDKN1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. MDM2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. CHEK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. HSP90AA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. CDK4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. BMPR1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. MUC16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. MAX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. ABL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. MLH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. ABL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. BRD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. FANCC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. MDM4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. TG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. GATA3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. CCND1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. SPEN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. CCDC6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. PRF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. FH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. CDH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. SMAD3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. HRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ERBB4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. CYP2D6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. KRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. LDH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. MSH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. RARA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. NCKIPSD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. FGFR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. BCR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. EP300
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. SDHB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. PALB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. POU5F1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. CALCB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. RAC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. RAF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. STAT5B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. DDIT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. FUS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. MAP2K1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. HER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. STK11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. FOXP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. ARID1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. TOP2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. CUX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. NBN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. PTPRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. SDHA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. TERT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. hCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. EZH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. MET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. JAK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. BRAF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. CREBBP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. PRKAR1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. FOXA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. CLIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. PTCH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. CD79A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. MYB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. ATR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. RHOH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. BRIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. NOTCH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. NFE2L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. SMAD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. BLM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. POLE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CALR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. NTRK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. SMAD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. PAM50
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. YWHAE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. FOXO3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. RET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. FES
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. WT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. CEP17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. FHIT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. GOPC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. HLA-A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CDK6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. ALK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. SOX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. ERCC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. PTPN11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. PTK6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. AFP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. ARNT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. ATP1A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. FANCD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. KMT2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. CASP8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. FLT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. PDGFRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. MYCN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. NKX2-1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. NRG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. TSC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. PPM1D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. ETV6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. CDH11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. CBL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. PPFIBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. PDCD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. AKT2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. NRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. MSH6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. CD274
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. TSC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. NF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. ENO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. REL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. NCOR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. ETV4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. MAP3K1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. VHL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. BIRC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. HMGA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. KLF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. SYK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. DICER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. WAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. FOXO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. NF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. FGFR4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. IDH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. TRA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. CgA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. NPM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. CYLD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. PML
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. IDH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. CIC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. NDRG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. NTRK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. STIL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. ETV5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. KLK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. MAF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. TCF7L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. TAL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. NCOR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. CCNE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. CTCF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. FGFR3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. PDGFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. RUNX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. TRIM27
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. GNAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. CDX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. FLT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. ERCC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. PMS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. SMO
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. JAK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. KEAP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. CTNNB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. DNMT3A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. ERG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. XPC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. Beta-hCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. IL6ST
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. MAP2K4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. NCOA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. NT5C2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. BUB1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. SMARCA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. TFRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. AXIN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. DDX5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. TNFRSF17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. ELN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. HMGA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. ERCC5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. RAD51B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. TBX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. NOTCH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. SEPT9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. ELF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. NCOA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. CCND2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. EIF3E
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. WRN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. Neurokinin
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. DROSHA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. SMARCB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. SND1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. TOP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. XPO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. BAP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. CDKN2C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. FUBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. MYD88
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. RPL10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. TGFBR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. APOBEC3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. BCL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. JAK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. MEN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. SDHC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. ARID1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. ATRX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. AXIN2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. SOCS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. SSX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. U2AF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. IHC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. CARS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. LASP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. MKL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. PAX8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. RECQL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. SPECC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. LCK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. MUTYH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. STAT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. EXT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. RAD21
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. SALL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. EIF4A2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. KLF6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. PCSK7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. FEV
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. GPC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. HEY1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. MYOD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. SUZ12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. TNFAIP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. UBR5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. EWSR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. MED12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. NUTM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. PAX5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. PIK3R1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. PLCG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. HOXD13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. MLLT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. PIM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. PPARG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. PTPN13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. TBL1XR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. CD74
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. CREB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. ETV1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. IGH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. LEF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. XPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. EBF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. EML4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. ERCC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. LIFR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. ZNF198
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. WFDC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. FANCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. NCOA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. NFIB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. NUMA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. PDGFRA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. PRDM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. SDHD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. WIF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. COL1A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. FANCF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. FOXP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. LCP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. B2M
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. BCL10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. COL2A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. CRTC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. DDX3X
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. KMT2D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. TET1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. WHSC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. ACVR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. ALDH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. MALAT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. MITF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. PER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. SETBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. TPR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. KMT2C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. MECOM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. MSN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. TET2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. TNFRSF14
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. BTG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. CBFA2T3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. DDB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. DNAJB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. KDM6A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. MAP2K2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. NR4A3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. PMS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. TCF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. CIITA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. HOXA9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. IL7R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. MALT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. NFATC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. NFKB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. RALGDS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. SF3B1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. SMARCE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. TMPRSS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. CCND3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. CNBP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. FLI1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. HERPUD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. MPL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. NONO
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. POT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. ZNF331
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. BTK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. CDK12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. CEBPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. NSD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. PBX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. PICALM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. SEPT5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. SFPQ
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. FANCE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. CASC5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. DDX6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. DEK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. EPS15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. IKBKB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. KDM5A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. MAML2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. MLLT11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. PDCD1LG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. SFRP4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. TTL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. WWTR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. CDC73
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. CREB3L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. DDR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. FGFR1OP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. FOXL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. HLF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. MN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. PAX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. TCL1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. TPM4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. TRIM24
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. TRRAP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. ABI1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. ATF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. BCL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. DAXX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. FOXO4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. GATA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. HSP90AB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. MLLT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. MYH9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. PBRM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. RANBP2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. RPL22
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. SETD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. WHSC1L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. AKAP9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. CANT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. CD79B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. ELL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. EPAS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. FAT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. FCGR2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. FLCN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. GNAQ
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. IKZF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. KDM5C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. KIF5B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. LMO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. NIN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. NUP214
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. PRCC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. PREX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. SRSF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. TPM3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. TRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. CBFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. GMPS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. HIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. HNF1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. KAT6B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. LMO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. LPP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. MYH11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. PCM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. PTPRK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. PTPRT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. RBM10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. TCF12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. TFE3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. TFG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. TRD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. ZBTB16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. SET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. ACVR2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. ARHGEF12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. BCL9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. BCL9L
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. CARD11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. ELK4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. ERC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. FBXO11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. GAS7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. GNA11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. HNRNPA2B1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. HOXC11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. KCNJ5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. LRP1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. MYCL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. NAB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. PRDM16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. PRKACA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. PRRX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. QKI
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. RABEP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. RBM15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. SDC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. SLC34A2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. SPOP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. SS18
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. ACKR3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. ACSL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. ARHGAP26
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. ARID2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. ASXL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. BCL11A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. BRD3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. CLTC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. FAT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. FSTL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. HOXA11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. NUP98
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. OLIG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. PLAG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. PPP2R1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. SDHAF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. SRGAP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. SUFU
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. TSHR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. USP6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. USP8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. ZRSR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. Cytokeratin fragment 21-1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. AFF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. AFF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. CACNA1D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. CAMTA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. CHD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. CNTRL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. COX6C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. EXT2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. EZR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. FIP1L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. GATA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. HOXD11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. IL21R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. IRF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. JAZF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. KTN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. LRIG3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. PAX7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. PHF6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. POU2AF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. PTPRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. RAP1GDS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. SBDS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. SH2B3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. SMARCD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. SRSF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. STAG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. TFEB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. TLX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. TRAF7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. TRIM33
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. ZNF278
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. MAP-Tau mRNA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. CD52
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. ACSL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. ATIC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. ATP2B3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. BCL11B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. BCL7A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. BCOR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. CBLC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. CCNB1IP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. CHIC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. CRTC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. CSF3R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. DCTN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. DDX10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. DNM2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. FNBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. H3F3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. HIST1H3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. HOXA13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. IGL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. KAT6A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. KIAA1598
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. LHFP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. MAP3K13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. MLLT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. MLLT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. MNX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. NACA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. NFKBIE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. PAFAH1B2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. PHOX2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. PPP6C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. RMI2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. RNF213
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. RNF43
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. RPN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. RSPO3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. SH3GL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. SSX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. SSX4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. TCEA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. TFPT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. TLX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. TMEM127
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. TRIP11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. VTI1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. ZFHX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. ZNF384
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. MK167
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. AFF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. AMER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. ASPSCR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. BCL5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. BCORL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. C12orf9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. C15orf65
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. C2orf44
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. CBLB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. CEP89
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. CHCHD7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. CLP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. CLTCL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. CNOT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. CREB3L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. CRLF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. DUX4L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. ECT2L
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. ETNK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. FAM131B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. FAM46C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. FCRL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. GOLGA5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. GPHN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. GRIN2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. H3F3A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. HIST1H4I
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. HMGN2P46
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. HOOK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. HOXC13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. IGK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. KDSR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. KIAA1549
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. LSM14A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. LYL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. LZTR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. MAFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. MDS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. MLF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. MLLT10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. MSI2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. MTCP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. MYO5A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. NUTM2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. NUTM2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. OMD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. P2RY8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. PDE4DIP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. PSIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. PWWP2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. RANBP17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. RNF217-AS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. RPL5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. RSPO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. RUNDC2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. RUNX1T1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. SEPT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. SLC45A3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. SS18L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. STRN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. TAF15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. TAL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. TCL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. THRAP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. ZCCHC8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. ZNF521
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. Nuclear matrix protein 22
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CAD-ALK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]